Market Tracker

01/23 6:05pm ET

Gilead Sciences Inc (NASDAQ:GILD)

105.54
Data as of Jan 23
 +0.40 / +0.38%
Today’s Change
63.50
Today|||52-Week Range
116.83
+11.97%
Year-to-Date

Today’s Trading

Previous close105.14
Today’s open104.40
Day’s range103.80 - 106.11
Volume9,593,491
Average volume (3 months)17,629,085
Market cap$159.2B
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+287.08%
Earnings growth (next 5 years)+28.28%
Revenue growth (last year)+16.72%
P/E ratio18.7
Price/Sales10.23
Price/Book14.24

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+0.24+0.15%
BIIBBiogen+3.88+1.10%
BAXBaxter International...-0.83-1.15%
GEVASynageva BioPharma C...+0.79+0.67%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateJanuary 27, 2015
EPS forecast (this quarter)$2.21
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts